Market overview
The global absorbable PGLA surgical sutures market is worth USD 853 mn in 2026 and is forecast to reach USD 1.3 bn by 2036, growing at a 4.0% CAGR. United States is the largest country market and Coated polyglactin 910 is the largest by type segment.
| Scope | Synthetic absorbable sutures made of polyglactin 910 (polyglycolic acid-lactide copolymer), including coated, rapid-absorbing and antibacterial-coated versions. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 820 mn |
| Value 2026 | USD 853 mn |
| Value 2036 | USD 1.3 bn |
| CAGR 2026-2036 | 4.0% |
| Volume 2026 | 175 million units |
| Volume 2036 | 235 million units |
| Average price 2026 | USD 4.87 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Absorbable PGLA Surgical Sutures market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 852.8 mn |
| 2027 | USD 886.9 mn |
| 2028 | USD 922.4 mn |
| 2029 | USD 959.3 mn |
| 2030 | USD 997.7 mn |
| 2031 | USD 1.04 bn |
| 2032 | USD 1.08 bn |
| 2033 | USD 1.12 bn |
| 2034 | USD 1.17 bn |
| 2035 | USD 1.21 bn |
| 2036 | USD 1.26 bn |
Absorbable PGLA Surgical Sutures market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Coated polyglactin 910 | 68.0% | 64.9% | USD 580 mn | 3.5% |
| Rapid-absorbing polyglactin | 14.0% | 13.4% | USD 119 mn | 3.5% |
| Antibacterial-coated polyglactin | 18.0% | 21.8% | USD 154 mn | 6.0% |
By surgery
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| General surgery | 34.0% | 32.7% | USD 290 mn | 3.6% |
| Obstetrics and gynaecology | 24.0% | 24.2% | USD 205 mn | 4.1% |
| Orthopaedic | 10.0% | 10.1% | USD 85 mn | 4.1% |
| Plastic and cosmetic | 12.0% | 12.7% | USD 102 mn | 4.6% |
| Cardiovascular and other | 20.0% | 20.2% | USD 171 mn | 4.1% |
By needle type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Round-bodied taper | 44.0% | 42.0% | USD 375 mn | 3.5% |
| Cutting | 36.0% | 36.0% | USD 307 mn | 4.0% |
| Blunt and specialty | 14.0% | 16.0% | USD 119 mn | 5.4% |
| Needle-free ties | 6.0% | 6.0% | USD 51 mn | 4.0% |
By suture size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fine sizes | 30.0% | 31.0% | USD 256 mn | 4.3% |
| Medium sizes | 44.0% | 43.0% | USD 375 mn | 3.8% |
| Heavy sizes | 26.0% | 26.0% | USD 222 mn | 4.0% |
By sales channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospital tenders | 56.0% | 53.0% | USD 478 mn | 3.4% |
| Distributors | 28.0% | 29.0% | USD 239 mn | 4.4% |
| Online and direct sales | 16.0% | 18.0% | USD 136 mn | 5.2% |
Top 25 countries for absorbable PGLA surgical sutures by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 77.5% of 2026 revenue and the 25 countries below together hold 94.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 256 mn | 30.0% | USD 362 mn | 3.5% |
| 2 | China | USD 102 mn | 12.0% | USD 175 mn | 5.5% |
| 3 | Germany | USD 51 mn | 6.0% | USD 69 mn | 3.1% |
| 4 | Japan | USD 51 mn | 6.0% | USD 66 mn | 2.5% |
| 5 | India | USD 51 mn | 6.0% | USD 96 mn | 6.5% |
| 6 | France | USD 34 mn | 4.0% | USD 45 mn | 2.9% |
| 7 | United Kingdom | USD 34 mn | 4.0% | USD 45 mn | 2.9% |
| 8 | Brazil | USD 34 mn | 4.0% | USD 53 mn | 4.5% |
| 9 | Italy | USD 26 mn | 3.0% | USD 34 mn | 2.9% |
| 10 | Spain | USD 21 mn | 2.5% | USD 29 mn | 3.1% |
| 11 | Canada | USD 14 mn | 1.6% | USD 19 mn | 2.9% |
| 12 | Mexico | USD 13 mn | 1.5% | USD 19 mn | 4.1% |
| 13 | Turkey | USD 12 mn | 1.4% | USD 19 mn | 5.2% |
| 14 | South Korea | USD 12 mn | 1.4% | USD 17 mn | 4.2% |
| 15 | Russia | USD 12 mn | 1.4% | USD 15 mn | 3.0% |
| 16 | Australia | USD 12 mn | 1.4% | USD 15 mn | 3.0% |
| 17 | Poland | USD 8.9 mn | 1.1% | USD 13 mn | 4.1% |
| 18 | Netherlands | USD 8.9 mn | 1.1% | USD 12 mn | 3.0% |
| 19 | Saudi Arabia | USD 8.9 mn | 1.1% | USD 15 mn | 5.2% |
| 20 | Indonesia | USD 8.9 mn | 1.1% | USD 15 mn | 5.2% |
| 21 | Argentina | USD 7.7 mn | 0.9% | USD 10 mn | 2.9% |
| 22 | Egypt | USD 7.7 mn | 0.9% | USD 13 mn | 5.2% |
| 23 | Iran | USD 7.7 mn | 0.9% | USD 10 mn | 2.9% |
| 24 | Pakistan | USD 7.7 mn | 0.9% | USD 14 mn | 6.2% |
| 25 | Thailand | USD 7.7 mn | 0.9% | USD 11 mn | 4.1% |
| Rest of world | USD 45 mn | 5.2% | USD 68 mn | 4.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Johnson & Johnson MedTech
- Medtronic
- Samyang Biopharmaceuticals
Group 2: Regional and specialist players
- B. Braun
- SMI AG
- Assut Europe
- Resorba Medical
- CP Medical
- Peters Surgical
- Mani
- Dynek
- Riverpoint Medical
- Surgical Specialties
Group 3: Emerging and niche players
- Healthium Medtech
- Dolphin Sutures
- Lotus Surgicals
- Aurolab
- DemeTECH
- Futura Surgicare
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the absorbable PGLA surgical sutures market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.0% is calculated from the resulting values.
The market is divided by type, by surgery, by needle type, by suture size, by sales channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the absorbable PGLA surgical sutures market?
The global absorbable PGLA surgical sutures market is estimated at USD 820 mn in 2025 and USD 853 mn in 2026.
How fast will the absorbable PGLA surgical sutures market grow?
It is forecast to reach USD 1.3 bn by 2036, a compound annual growth rate of 4.0% from 2026, an increase of USD 410 mn.
Which country is the largest market for absorbable PGLA surgical sutures?
United States is the largest market by revenue at USD 256 mn in 2026, 30.0% of the global total. The three largest countries together hold 48.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 6.5% a year from 2026 to 2036.
Which absorbable PGLA surgical sutures segment is largest?
In the by type split, Coated polyglactin 910 is the largest segment with 68.0% of 2026 revenue.
Who are the leading absorbable PGLA surgical sutures companies?
Global leaders include Johnson & Johnson MedTech, Medtronic, Samyang Biopharmaceuticals.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Perimenopause Nutrition ProductsUSD 852 mn · 6.0% CAGR
- AI-powered Spinal SurgeryUSD 881 mn · 12.0% CAGR
- Vaginitis Screening AssaysUSD 821 mn · 7.5% CAGR
- Neurofibromatosis TherapeuticsUSD 889 mn · 11.0% CAGR
- Endoscopic Closure SystemsUSD 817 mn · 7.0% CAGR
- Behavioral Health Care CoordinationUSD 806 mn · 11.0% CAGR
- AI-powered Care CoordinationUSD 905 mn · 14.0% CAGR
- Vaporized Hydrogen Peroxide Sterilization SystemUSD 905 mn · 7.0% CAGR
← Absorbable PGA Surgical Sutures Absorbance Micro plate Reader →